Unlikely to cause harm — often a labeling or packaging issue.
Failed Dissolution Specifications
| Brand name | FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI |
| Generic name | FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI |
| Active ingredient(s) | FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE |
| Distributed by / for | Walgreen Co, 200 Wilmot Rd., Deerfield, IL 60015 |
| NDC | 0363-1606-20 |
| Full product label | Wal-Fex D, Fexofenadine HCl 60mg/Antihistamine & Pseudoephedrine HCl 120mg/Nasal Decongestant, Extended Release Tablets USP, a) 20 Extended Release Tablets per box, NDC 0363-1606-20, b) 30 Extended Release Tablets per box, NDC 0363-1606-30, Distributed by: Walgreen Co, 200 Wilmot Rd., Deerfield, IL 60015, Made in India. |
| Recalling firm | Dr. Reddy's Laboratories, Inc. |
| Distribution | Nationwide in the USA |
| Quantity | 67,848 boxes |
| Recall initiated | 2022-01-04 |
| Report date | 2022-01-26 |
| Recall completed | 2023-10-20 |
| Recall number | D-0378-2022 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗